Latest News
For families facing the end-of-life of a loved one with pediatric cancer, robust quality measures to benchmark what parents value most in their child’s medical care do not currently exist. A new study from Yale Cancer Center helps identify what parents prioritize for their children with advanced cancer, including alleviating the child’s symptoms and honoring the family’s goals and wishes. Researchers say the findings may help establish a patient-centered agenda for quality measurement and improvement in children with advanced, incurable cancer. The study titled, "Parent Priorities in End-of-Life Care for Children with Cancer,” was published in JAMA Network Open on May 15.
- May 04, 2023
Connecticut Magazine’s 2023 'Top Doctors' list includes more than 250 Yale Medicine physicians who were selected by their peers as the best in their fields. Forty-two of them are from Yale Pediatrics!
- May 03, 2022
Connecticut Magazine has named 87 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2022 Best Doctors guide.
- May 02, 2022Source: Yale Medicine
Connecticut Magazine’s 2022 'Top Doctors' list includes more than 200 Yale Medicine physicians who were selected by their peers as the best in their fields.
- May 25, 2021
The Women’s Leadership Resource Library launched online in April. The fully digital lending library, available to anyone with Yale Library access, includes books, podcasts, TED talks, online courses and other resources that address topics like building confidence, embracing vulnerability, knowing your worth, responding in crisis, and the soft skills needed to become an effective leader.
- February 13, 2018Source: JAMA Medical News & Perspectives
A perspective piece on the state of medical marijuana access for children with serious, life-threatening illness
- December 11, 2017
New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are more cautious than those who aren’t. The findings also show clinicians would prefer to see much stronger clinical evidence that marijuana treatments can help in relieving symptoms, such as nausea and pain.